Sanofi’s profits to dip as its dengue vaccine faces dire criticism

Date: 2017-11-30   Author: Saipriya Iyer  Category: #news

Sanofi’s profits to dip as its dengue vaccine faces dire criticism

In a turning tide of the events, the use of Sanofi’s new vaccine for dengue has been severely restricted, owing to the evidence that it can lead to further deterioration in patients who have not been infected with the ailment before. The chief officials of Sanofi are expected to make suggestions to the national regulatory authorities in France that the vaccination should not be prescribed for patients who have no history of being infected by dengue.

As per medical experts, results obtained from the clinical tests performed on the patients a few years earlier depicted that the Dengvaxia vaccine offered a constant shield against dengue to those patients who were earlier affected due to the ailment. However, later on, it was found that people who were not afflicted by the virus suffered much more post the vaccination.

Initially, the firm had predicted bright growth prospects for its dengue vaccine, projecting that it would accrue a revenue of nearly EUR 1 billion per year from its sales. But, as per the estimates its sales in 2016 were assessed at EUR 55 million, much below expectations. A reliable research group has forecast that the yearly sales of Dengvaxia vaccine will reach EUR 360 million by 2022.  Sources have claimed that dengue infects millions across the globe and nearly 20,000 persons lose their lives due to the disease each year.

Though Sanofi’s Dengvaxia is the first approved vaccine of its kind, research has already depicted the limitations of vaccination through mixed results obtained from the data of clinical tests conducted on four dissimilar kinds of virus. It is anticipated that the business rivals of the firm such as Takeda Pharmaceutical are also developing an improved version of a vaccine against dengue, which can significantly impact Sanofi’s market position over the coming years.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Hard Disk Drive Market Development, Growth, Trends, Demand, Share, Analysis and Forecast 2026

Author: Ashwin Naphade

A recent research on ' Hard Disk Drive market', now available with Market Study Report, LLC, is a thorough study on the latest market trends prevailing in the global business sphere. The report also offers important details pertaining to market sh...


Service Delivery Platform Market with manufacturers, Application, regions and SWOT Analysis 2026

Author: Ashwin Naphade

Market Study Report, LLC, has added a research study on ' Service Delivery Platform market' which delivers a concise outline of the market share, market size, revenue estimation, geographical outlook and SWOT analysis of the business. The ...


Shower Heads and Systems Market Analysis: Global Industry Trends, Share, Key Players, Size, Forecast to 2026

Author: Ashwin Naphade

Market Study Report, LLC, now offers a research study on ' Shower Heads and Systems market' which offers a precise outline of the industry valuation, SWOT Analysis, market size, revenue estimation and the geographical outlook of the business. The ...